Cellular Therapies

Shares of Vericel Corp (NASDAQ: VCEL), a developer of cellular therapies for use in the treatment of patients with diseases and conditions, were trading higher by nearly 4 percent on Tuesday morning. The move higher in Vericel's stock follows the company's announcement on Monday that it has...